[
    [
        {
            "time": "",
            "original_text": "欧普康视：公司的阿托品已完成院内制剂开发中的中试部分",
            "features": {
                "keywords": [
                    "欧普康视",
                    "阿托品",
                    "院内制剂",
                    "中试"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "欧普康视：公司的阿托品已完成院内制剂开发中的中试部分",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药周报：深入推广三明医改模式 以下领域有望受益",
            "features": {
                "keywords": [
                    "医药周报",
                    "三明医改",
                    "推广",
                    "受益"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药周报：深入推广三明医改模式 以下领域有望受益",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]